Nucleai Email Format
Software DevelopmentIllinois, United States51-200 Employees
Nucleai, a mid-sized software company based in Chicago, Illinois, develops AI-powered software that applies spatial biology to advance precision medicine, supporting drug development and treatment decisions. Its Atom platform is a leading offering in this space, and the company licenses its research platform for internal use by pharmaceutical firms while also collaborating on biomarker discovery projects. Nucleai’s customers are pharmaceutical developers seeking to identify predictive biomarkers and improve patient outcomes through spatial proteomics and related analyses. In 2026, it announced an integrated spatial proteomics solution for pharma drug development in partnership with Sirona Dx. The company has been recognized in the field as a Top 10 Spatial Biology Company of 2025 and has presented data at industry events such as SITC 2025.